6 completed. 1 Early Phase 1, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Stage IB Ovarian Cancer: new trials by email Literature Review of Stage IB Ovarian Cancer trials Research Report on Stage IB Ovarian Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer Diagnostic Microscopy, Fluorescein Sodium Injection, Laboratory Biomarker Analysis - Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Early Phase 1 | Completed | Roswell Park Cancer Institute | 19 | 2017-11-06 | 2021-10-06 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors Informational Intervention - Stage I Breast Cancer, Stage I Cervical Cancer | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 40 | 2015-08-01 | 2025-04-29 |
| Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Laboratory Biomarker Analysis, Pharmacological Study - Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma | Phase 1 | Completed | Roswell Park Cancer Institute | 18 | 2012-03-01 | 2016-10-04 |
| OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission Laboratory Biomarker Analysis, Polyvalent Antigen-KLH Conjugate Vaccine, Saponin-based Immunoadjuvant OBI-821 - Stage IA Fallopian Tube Cancer, Stage IA Ovarian Cancer | Phase 2 | Completed | Gynecologic Oncology Group | 171 | 2010-07-01 | 2017-09-13 |
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Cognitive Assessment, Quality-of-Life Assessment - Cognitive Side Effects of Cancer Therapy, Malignant Ovarian Epithelial Tumor | Completed | Gynecologic Oncology Group | 247 | 2010-04-01 | 2018-04-12 | |
| Collecting Tumor Samples From Patients With Gynecological Tumors Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor | Completed | Gynecologic Oncology Group | 275 | 1992-06-01 | 2016-10-28 |
Ovarian Neoplasms (6) · Fallopian Tube Neoplasms (4) · Breast Neoplasms (2) · Brenner Tumor (2) · Melanoma (2) · Uterine Cervical Neoplasms (2) · Astrocytoma (1) · Brain Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Dysgerminoma (1) · Esophageal Neoplasms (1) · Gestational Trophoblastic Disease (1) · Glioblastoma (1)
Adnexal Diseases (6) · Endocrine Gland Neoplasms (6) · Endocrine System Diseases (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Genital Diseases (6) · Genital Diseases, Female (6) · Genital Neoplasms, Female (6) · Gonadal Disorders (6) · Neoplasms (6) · Neoplasms by Site (6) · Ovarian Diseases (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Fallopian Tube Diseases (4)
Fluorescein (1) · Fluoresceins (1) · Mental Status and Dementia Tests (1) · Sirolimus (1)
Gynecologic Oncology Group (3) · Roswell Park Cancer Institute (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (6)
Andrea Barsevick, PhD (1) · Emese Zsiros, MD (1) · Kunle Odunsi (1) · Lisa Hess (1) · Michael Cibull (1) · Paul Sabbatini (1)
U10CA180868 (2), P30CA016056 (1), R01CA158318 (1), U10CA027469 (1), U10CA101165 (1)